About | Free Trial

Last Update

2012-05-25T00:00:00.000Z

This profile was last updated on // .

Is this you? Claim your profile.

Wrong Gary Woodnutt?

Dr. Gary Woodnutt Woodnutt

Editorial Board

Antimicrobial Agents

Antimicrobial Agents

Background Information

Employment History

Position, Pharmaceutical Industry
GlaxoSmithKline plc

Senior Vice President and Chief Scientific Officer
Lpath , Inc.

Affiliations

Speakers and Advisor
IBC USA Conferences , Inc.

Parent Member
Del Mar Union School District

Education

B.S. degree
Biochemistry and Physiology
University of Leeds

Bachelors degree
Biochemistry and Physiology
Leeds University

Ph.D

Ph.D degree
Biochemistry and Physiology
University of Reading

PhD

Reading University

Web References (35 Total References)


CovX: company > management

www.covx.com [cached]

Gary Woodnutt, PhD

...
Gary Woodnutt, PhD , joined CovX in March, 2006 as head of biology and brings more than 25 years of experience in the pharmaceutical industry. Before joining CovX, Dr. Woodnutt was head of pharmaceutical research and development at Diversa where he oversaw all efforts related to the optimization of therapeutic proteins and small molecule discovery. Prior to Diversa, he was at GlaxoSmithKline where he was vice president of biology, microbial, musculoskeletal and proliferative disease CEDD and responsible for discovery and non-clinical development and market support activities in the anti-infective and host defense areas. During his time with GlaxoSmithKline, Dr. Woodnutt contributed to multiple IND and NDA filings for anti-infective drugs. He is on the editorial board of Antimicrobial Agents and Chemotherapy and is a section editor for Drug Discovery Today: Therapeutic Strategies and Current Opinion in Biotechnology. He received his Bachelors degree in Biochemistry and Physiology from Leeds University, UK and his PhD from Reading University, UK.


Gary Woodnutt, ...

www.sec.gov [cached]

Gary Woodnutt, Ph.D.

...
Gary Woodnutt Ph.D.
Senior Vice President and Chief Scientific Officer
Dr. Woodnutt joined Lpath in April 2013. Prior to joining Lpath, Dr. Woodnutt served as the Vice President, Open Innovation at CovX, a division of Pfizer acquired in 2007, from 2012 to 2013, and as Vice President of Biology Research from 2006 to 2012. From 2002 to 2006, Dr. Woodnutt was the Senior Vice President of Pharmaceutical Research and Development for Diversa Corporation. He began his career in the pharmaceutical industry with Glaxo SmithKline Pharmaceuticals, where he was employed for more than 20 years and rose to the position of Vice President and Head of Biology in the Antimicrobial and Host Defense Group. Dr. Woodnutt received his Ph.D. in biochemistry/physiology from the University of Reading, and he has authored numerous scientific articles.


Executive Team | The Lpath Team | Lpath Incorporated

www.lpath.com [cached]

Gary Woodnutt, Ph.D. - Sr. Vice President & Chief Scientific Officer

Background: Dr. Woodnutt brings to Lpath extensive experience in drug discovery and pharmaceutical research. Prior to joining Lpath, Dr. Woodnutt served as the Vice President, Open Innovation at Pfizer/CovX, but his primary role at CovX, from 2006 to 2012, was as Vice President of Biology Research. From 2002 to 2006, Dr. Woodnutt was the Senior Vice President of Pharmaceutical Research and Development for Diversa Corporation. He began his career in the pharmaceutical industry with Glaxo SmithKline Pharmaceuticals, where he was employed for more than 20 years and rose to the position of Vice President and Head of Biology in the Antimicrobial and Host Defense Group. Dr. Woodnutt received his Ph.D. in biochemistry/physiology from the University of Reading, and he has authored numerous scientific articles.


Company Summary | About Lpath | Lpath Incorporated

www.lpath.com [cached]

Gary Woodnutt, Ph.D., SVP & Chief Scientific Officer: over 25 years experience in drug discovery and pharmaceutical research with companies including GSK and Pfizer.


Gary Woodnutt, Ph.D., Vice ...

www.PEGSummit.com [cached]

Gary Woodnutt, Ph.D., Vice President, Biology, CovX Pharmaceuticals, Inc., Pfizer

The utility of molecules that interact with two (or more) targets or that can interact in two places on the same target is generating much interest.

Similar Profiles

Other People with this Name

Other people with the name Woodnutt

Mark Woodnutt
The Stop Community Food Centre

Kelly Woodnutt
Hellenic Republic

Natasha Woodnutt
Bohmers Tree Care Gallery

Kevin Woodnutt
Novartis AG

Clive Woodnutt
Bohmers Tree Care Gallery

Browse ZoomInfo's Business Contact Directory by City

Browse ZoomInfo's
Business People Directory

Browse ZoomInfo's
Advanced Company Directory